124 related articles for article (PubMed ID: 8438149)
21. Ethics. Senate probe of research psychiatrists.
Kaiser J
Science; 2009 Jul; 325(5936):30. PubMed ID: 19574367
[No Abstract] [Full Text] [Related]
22. In tight times, companies fill the funding gap.
Savage N
Cell; 2015 May; 161(4):699-701. PubMed ID: 25957675
[TBL] [Abstract][Full Text] [Related]
23. The antibiotic pipeline.
Kunin CM
N Engl J Med; 2004 Nov; 351(19):2019-20. PubMed ID: 15525731
[No Abstract] [Full Text] [Related]
24. The NIH budget and the future of biomedical research.
Loscalzo J
N Engl J Med; 2006 Apr; 354(16):1665-7. PubMed ID: 16625006
[No Abstract] [Full Text] [Related]
25. US stem cell policy comes under fire.
Fletcher L
Nat Biotechnol; 2001 Oct; 19(10):893-4. PubMed ID: 11581638
[No Abstract] [Full Text] [Related]
26. The $2.6 billion pill--methodologic and policy considerations.
Avorn J
N Engl J Med; 2015 May; 372(20):1877-9. PubMed ID: 25970049
[No Abstract] [Full Text] [Related]
27. Taking the profit out of biomedical research tools.
Flores MA
Nat Biotechnol; 1999 Aug; 17(8):819-20. PubMed ID: 10429252
[TBL] [Abstract][Full Text] [Related]
28. The case for a new national program for the development of cancer therapeutics.
Schein PS
J Clin Oncol; 2001 Jun; 19(12):3142-53. PubMed ID: 11408512
[No Abstract] [Full Text] [Related]
29. NIH urged to cap profits made on publicly funded research.
Macilwain C
Nature; 2000 Jul; 406(6791):5. PubMed ID: 10894508
[No Abstract] [Full Text] [Related]
30. Comparative effectiveness casts first shadows across US industry.
Waltz E
Nat Biotechnol; 2009 Mar; 27(3):211-2. PubMed ID: 19270651
[No Abstract] [Full Text] [Related]
31. Natural products in drug discovery--organizing for success.
McChesney JD
P R Health Sci J; 2002 Jun; 21(2):91-5. PubMed ID: 12166030
[No Abstract] [Full Text] [Related]
32. The NIH, research institutions and industry: working together on a shared goal.
Omary MB
Gastroenterology; 2007 May; 132(5):1647-50. PubMed ID: 17484859
[No Abstract] [Full Text] [Related]
33. National Institute of Allergy and Infectious Diseases Challenge Grants designed to spark development of drugs to combat infectious diseases.
SoRelle R
Circulation; 2000 Oct; 102(15):E9030-1. PubMed ID: 11183866
[No Abstract] [Full Text] [Related]
34. Health care innovation in an era of cost containment.
White JK
Health Aff (Millwood); 1985; 4(2):105-18. PubMed ID: 4043922
[No Abstract] [Full Text] [Related]
35. AIDS research. Drug trials without the drugs?
Cohen J
Science; 2003 May; 300(5623):1212-3. PubMed ID: 12764159
[No Abstract] [Full Text] [Related]
36. New "21st Century Cures" Legislation: Speed and Ease vs Science.
Kesselheim AS; Avorn J
JAMA; 2017 Feb; 317(6):581-582. PubMed ID: 28056124
[No Abstract] [Full Text] [Related]
37. Sponsorship and Funding for Gene Therapy Trials in the United States.
Kassir Z; Sarpatwari A; Kocak B; Kuza CC; Gellad WF
JAMA; 2020 Mar; 323(9):890-891. PubMed ID: 32125392
[TBL] [Abstract][Full Text] [Related]
38. Razing the tollbooths. A call for restricting patents on basic biomedical research.
Stix G
Sci Am; 2003 Apr; 288(4):37. PubMed ID: 12661312
[No Abstract] [Full Text] [Related]
39. Drugs institute gives grant for cocaine vaccine.
Nadis S
Nature; 1996 Aug; 382(6592):568. PubMed ID: 8757117
[No Abstract] [Full Text] [Related]
40. NIH 'glues' cell biologists together.
Dove A
Nat Med; 2000 Oct; 6(10):1072. PubMed ID: 11017123
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
